placebo-controlled trial comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Last reviewed on 2025-10-11. Where a claim depends on a specific study, the study is described rather than over-claimed.
After subcutaneous administration, plasma concentrations rise within roughly thirty minutes and the elimination half-life is short, on the order of two to three hours. Reported physiological responses include transient increases in blood pressure and nausea, which tended to diminish with repeated dosing in trial settings. Because the peptide clears quickly, effects are not expected to persist long after a dose. Absorption from non-injected routes is poorly characterised, and nasal delivery produced variable plasma levels in older work.
Clinical research typically uses randomised, double-blind, placebo-controlled designs. The most common primary endpoint is the desire domain score of the Female Sexual Function Index, sometimes paired with a distress measure. Secondary outcomes include arousal, satisfaction, and event-based counts of satisfying sexual episodes. Across trials, average improvements are modest and individual responses vary widely. Whether benefits persist beyond a few months, and whether they depend on baseline hormone status, remain open questions rather than settled findings.
Melanocortin receptors form a family of five G-protein-coupled receptors designated MC1 through MC5. Bremelanotide binds most strongly at MC4R and MC1R, with weaker activity reported at MC3R and MC5R. MC4R is expressed in hypothalamic nuclei that coordinate energy balance and aspects of sexual behaviour. The prevailing interpretation is that central MC4R activation, rather than peripheral vascular effects alone, drives the reported changes in desire. This account remains partly inferential, since direct receptor-level measurement in living humans is not practical.
Published discussion sits at the intersection of peptide chemistry, neuroendocrinology and sexual medicine. Trial reports emphasise change scores on validated instruments, while mechanistic papers focus on hypothalamic circuits and receptor selectivity. Because placebo response in this field is large, effect sizes are usually reported with confidence intervals rather than as isolated averages. Reviews note that female and male data sets are not interchangeable and should be read separately. Diagnostic terminology has been revised over time, which complicates comparison between older and newer studies.
Bremelanotide is a synthetic cyclic heptapeptide that acts on a family of G-protein-coupled receptors. It was designed as a structural analogue of alpha-melanocyte-stimulating hormone, the endogenous peptide associated with pigmentation and several central signalling pathways. A lactam bridge constrains the ring and slows enzymatic breakdown, which distinguishes it from the linear parent molecule. Research interest moved over time from pigment biology toward central nervous system effects, particularly circuits connected to sexual desire. Parenteral delivery is used because oral bioavailability is poor.
Early clinical work used an intranasal formulation, and later programmes switched to subcutaneous delivery for more consistent absorption. A subcutaneous product received regulatory approval in the United States in 2019 for premenopausal women with acquired, generalised hypoactive sexual desire disorder. Approval followed phase 3 trials in which active treatment separated from placebo on desire and distress measures, though the average difference was modest. Labeling carries a caution about transient blood pressure elevation, so cardiovascular history is assessed before prescribing. Questions about durability of benefit beyond several months remain open.
| Property | Value | Notes |
|---|---|---|
| Primary receptor targets | MC4R and MC1R | Agonist activity; MC3R and MC5R weaker |
| Route studied in trials | Subcutaneous injection | Intranasal form was not approved |
| Elimination half-life | Approximately 2–3 hours | Short relative to the dosing interval |
| Common analytical method | Liquid chromatography–tandem mass spectrometry | Used for peptide quantification in plasma |
| Reported adverse events | Nausea, flushing, headache | Transient blood pressure rise also noted |
The peptide contains seven amino acids arranged in a ring, closed by a lactam bridge between a side-chain acid and an amine. This cyclic constraint holds the backbone in a defined conformation and increases resistance to enzymatic breakdown relative to linear analogs. N-terminal acetylation and a C-terminal amide further protect the molecule from exopeptidases. The result is a compound with a comparatively long circulation time for a small peptide. Structural modification of the bridge alters receptor affinity, which is one reason analogs in this family differ in their subtype preferences.
Whether the behavioral effect originates centrally, peripherally, or through both remains an active question. Animal experiments using receptor antagonists and site-specific injections point toward hypothalamic melanocortin circuits as a key locus, but translating those findings to humans is not straightforward. Blood pressure changes observed in trials suggest a vascular component that may be peripherally mediated. The relationship between receptor occupancy and reported effect has not been mapped in humans, and no validated biomarker predicts response. This gap makes it difficult to explain individual variability on pharmacological grounds alone.
How receptor activation translates into a change in desire is not established in detail. Proposed steps include modulation of dopaminergic signalling in reward circuits and downstream effects on autonomic tone. Human data consist mainly of clinical trials measuring self-reported outcomes rather than direct measurements of brain activity or transmitter release. The transient rise in blood pressure sometimes observed after administration is likewise reported consistently but explained only partly by known melanocortin pathways.
Melanocortin receptors form a family of five G-protein-coupled proteins, labelled MC1R through MC5R, that respond to peptides derived from pro-opiomelanocortin. Alpha-melanocyte-stimulating hormone and adrenocorticotropic hormone are the best-known endogenous ligands. The receptors are distributed differently across tissues, so a single agonist can produce effects in the brain, skin, adrenal gland and vasculature. This distribution explains why one peptide can influence both pigmentation and motivated behaviour.
Early work on melanocortin analogs in the 1980s and 1990s produced peptides intended to influence pigmentation and appetite. One of these, melanotan II, was observed to affect sexual desire as an incidental finding in self-administration reports. Researchers then pursued analogs with altered receptor selectivity and improved handling characteristics, and PT-141 emerged from that program in the late 1990s. The development path moved from dermatology and metabolism toward a central nervous system application, a shift that shaped both trial designs and the eventual label.
Regulatory review of bremelanotide concluded in 2019 with approval in the United States for a defined indication in premenopausal women. The reviewed formulation is a single-use prefilled autoinjector given subcutaneously, and its label carries cardiovascular monitoring language tied to blood pressure changes recorded during trials. Availability outside the approving jurisdiction varies, and in several countries the compound remains unapproved or is handled as a prescription-only item. Compounded and research-grade material also circulates, and it differs from the reviewed product in purity, characterization, and chain of custody.
==== 2019: Ankle screw malfunction ==== Complications with McCormick's leg injuries and the resulting surgeries plagued him for years thereafter. During post-injury surgery, a screw was placed into McCormick's ankle as an anchor for a surgical suture to hold a ligament in place. McCormick had initially appeared to recovered from his surgery well; in April 2019, The Oregonian described his injuries as "fully healed" and described McCormick as "fully recovered" prior to Oregon's spring football game on April 20. But less than one month after the spring football game, new swelling and pain arose in McCormick's left ankle. The screw had failed, and had caused another fracture. Doctors, however, had initially misidentified the injury as being a stress fracture arising from overuse, and recommended that McCormick merely rest in order for his ankle to heal. Rest was ineffective at resolving McCormick's pain in the long run; sharp pain resumed after McCormick worked out, and the true cause of the pain—the malfunctioning of the anchor—was not discovered by doctors until shortly before the third game of the 2019 Oregon Ducks football season. McCormick tried to play for part of that third game, hoping to delay surgery until after the football season, but he could not bear the pain—a second left ankle surgery, to replace the anchor, was performed, and his season once again came to an early end.
One of the first projects of the Free State was the design and production of the Great Seal of Saorstát Éireann which was carried out on behalf of the Government by Hugh Kennedy. The Statute of Westminster 1931, implementing the Balfour Declaration of 1926 by an Imperial Conference into British law, enabled each dominion to enact new legislation and change any extant legislation, without resorting to the U.K. Parliament (or any Crown intermediary). Extant legislation includes any and all Dominion legislation enacted prior to the Statute of Westminster. It also removed Westminster's authority to legislate for the Dominions, except by the express request and consent of the relevant Dominion's parliament. This change made the dominions, including the Free State, de jure independent nations—thus fulfilling Collins' vision of having "the freedom to achieve freedom". The Free State symbolically marked these changes in two mould-breaking moves soon after winning internationally recognised independence:
== Biodistribution and mechanisms of action == Lithium compartmentalization was studied in 11 biosubstrates of rats when lithium ascorbate was taken at a dose of 1000 mg/kg. As part of a tubeless analysis of the dynamics of concentrations in whole blood, the following values of the pharmacokinetic parameters of lithium ascorbate were obtained: Cmax=50.59 µg/l, tmax=1.50 h, Clast=33.7 µg/l, AUCt=1750 µg/l*h, MRTt=22.9 h, Lz=0.005 1/h, T1/2=141 h, CL=0.029 l/h, Vd=5.9 l. Multichamber pharmacokinetic analysis showed that the stabilization of lithium levels in the blood is maintained by a special "depot" of lithium, apparently consisting of the aorta, femur and brain. Application of the method of functional linkage analysis suggested that the targeted accumulation of ascorbate anion in cells is due to the activity of vitamin C transport proteins SLC23A1, SLC23A2, SLC23A3. At the same time, lithium ions and ascorbate exhibit a synergistic effect. The main effects of lithium include the support of normal excitability central nervous system: by preventing excessive concentration of norepinephrine, regulation of sodium concentration in muscle cells (which is important for the tone of blood vessels), sensitivity of neurons to dopamine, which reduces the negative impact of stress.
Some enzymes need to go through a maturation process to be activated. A precursor (inactive state, better known as zymogen) is first synthesized, and then, by cutting some specific peptide bonds (enzymatic catalysis by hydrolytic selective split), its 3D conformation is highly modified into a catalytic functional status, obtaining the active enzyme. Proteolysis is irreversible and normally a non-specific process. The same activator can modulate different regulatory enzymes : once trypsin is activated, it activates many other hydrolytic enzymes. Proteolysis can also be fast and simple so the hydrolysis of a single peptide bond can be enough to change the conformation of the protein and build an active zone, allowing the interaction between the enzyme and the substrate, for instance, chymotrypsin activation (as it can be seen in the images). Many different types of proteins with different roles in metabolism are activated by proteolysis for big reasons:
The First World War occurred from 1914 to 1918. In terms of human technological history, the scale of World War I was enabled by the technological advances of the Second Industrial Revolution and the resulting globalization that allowed global power projection and mass production of military hardware. It had been recognized that the complex system of opposing military alliances (the German and Austro-Hungarian Empires against the British, Italian, Russian, and French Empires) was likely, if war broke out, to lead to a worldwide conflict. That caused a very minute conflict between two countries to have the potential to set off a domino effect of alliances, triggering a world war. The fact that the powers involved had large overseas empires virtually guaranteed that such a war would be worldwide, as the colonies' resources would be a crucial strategic factor. The same strategic considerations also ensured that the combatants would strike at each other's colonies, thus spreading the wars far more widely than those of pre-Columbian times. War crimes were perpetrated in World War I. Chemical weapons were used in the war despite the Hague Conventions of 1899 and 1907 having outlawed the use of such weapons in warfare. The Ottoman Empire was responsible for the Armenian genocide, during the First World War, as well as other war crimes.
Sources: en.wikipedia.org
== Corruption == Corruption Perceptions Index 2019: Thailand ranked 101 of 180 nations (1=cleanest; 180=most corrupt). Other ASEAN nations ranked: Singapore, 4; Brunei, 35; Malaysia, 51; Indonesia, 85; Vietnam, 96; Philippines, 113; Myanmar, 130; Laos, 130 (tie); and Cambodia, 162. Corruption Perceptions Index 2018: Thailand ranked 99 of 180 nations (1=clean; 180=most corrupt). Other ASEAN nations ranked: Singapore, 3; Brunei, 31; Malaysia, 61; Indonesia, 89; Philippines, 99 (tie); Vietnam, 117; Myanmar, 132; Laos, 132 (tie); and Cambodia, 161. Corruption Perceptions Index 2017: Thailand ranked 96 of 180 nations (1=clean; 180=most corrupt). Other ASEAN nations ranked: Singapore, 6; Brunei, 32; Malaysia, 62; Indonesia, 96 (tie); Vietnam, 107; Philippines, 111; Myanmar, 130; Laos, 135; and Cambodia, 161. Corruption Perceptions Index 2016: Thailand ranked 101 of 176 nations (1=clean; 176=most corrupt). Other ASEAN nations ranked: Singapore, 7; Brunei, 41; Malaysia, 56; Indonesia, 90; Philippines, 101; Vietnam, 113; Laos, 123; Myanmar, 136; and Cambodia, 156. Corruption Perceptions Index 2015: Thailand ranked 76 of 167 nations (1=clean; 167=most corrupt) on this annual survey. Other ASEAN nations were ranked: Singapore, 8; Malaysia, 54; Indonesia, 88; Philippines, 95; Vietnam, 112; Laos, 139; Myanmar, 147; and Cambodia, 150. Corruption Perceptions Index 2014: Transparency International's CPI 2014 ranked Thailand 85 of 174 countries (1=clean; 174=most corrupt).
=== Principles of rhinoplastic reconstruction === Principles The technical principles for the surgical reconstruction of a nose derive from the essential operative principles of plastic surgery: that the applied procedure and technique(s) yield the most satisfactory functional and aesthetic outcome. Hence, the rhinoplastic reconstruction of a new nasal subunit, of virtually normal appearance, can be done in a few procedural stages, using intranasal tissues to correct defects of the mucosa; cartilage battens to brace against tissue contraction and depression (topographic collapse); axial skin flaps designed from three-dimensional (3-D) templates derived from the topographic subunits of the nose; and the refinement of the resultant correction with the subcutaneous sculpting of bone, cartilage, and flesh. Nonetheless, the physician-surgeon and the rhinoplasty patient must abide the fact that the reconstructed nasal subunit is not a nose proper, but a collagen-glued collage—of forehead skin, cheek skin, mucosa, vestibular lining, nasal septum, and fragments of ear cartilage—which is perceived as a nose only because its contour, skin color, and skin texture are true to the original nose.
In biology, methylene blue is used as a dye for a number of different staining procedures, such as Wright's stain and Jenner's stain. Since it is a temporary staining technique, methylene blue can also be used to examine RNA or DNA under the microscope or in a gel: as an example, a solution of methylene blue can be used to stain RNA on hybridization membranes in northern blotting to verify the amount of nucleic acid present. While methylene blue is not as sensitive as ethidium bromide, it is less toxic and it does not intercalate in nucleic acid chains, thus avoiding interference with nucleic acid retention on hybridization membranes or with the hybridization process itself. It can also be used as an indicator to determine whether eukaryotic cells, such as yeast, are alive or dead. The methylene blue is reduced in viable cells, leaving them unstained. However, dead cells are unable to reduce the oxidized methylene blue, and the cells are stained blue. Methylene blue can interfere with the respiration of the yeast as it picks up hydrogen ions made during the process.
== Other epitope-tag combinations == The principle of tandem-affinity purification of multiprotein complexes is not limited to the combination of CBP and Protein A tags used in the original work by Rigaut et al. (1999). For example, the combination of FLAG- and HA-tags has been used since 2000 by the group of Nakatani to purify numerous protein complexes from mammalian cells. Many other tag combinations have been proposed since the TAP principle was published.
Sources: en.wikipedia.org
Trial results generally show a small to moderate average improvement in desire scores relative to placebo. The distribution of responses is wide, and some participants show little measurable change. Group averages should not be read as a prediction for any single person.
Nausea, flushing, headache, and transient blood pressure elevation are the most frequently reported events. These typically appear shortly after dosing and are usually described as mild to moderate in severity. Safety data covering long periods of continuous use remain limited.
A short half-life means the compound clears from circulation within hours, so any effect is tied closely to dosing time. Accumulation between doses is therefore unlikely under the studied schedule. The practical consequence is that timing of administration shapes what observers record.
It is a synthetic cyclic peptide that activates melanocortin receptors. It is given by injection and was approved in the United States in 2019 for a specific low-desire diagnosis in premenopausal women. It is not a hormonal therapy.